Heron Therapeutics, Inc. (HRTX) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Heron Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:06.156 Good day and thank you for standing by. Welcome to the Heron Therapeutics Q1 2025 00:00:06.156 -- 00:00:10.500 conference call. At this time, all participants are in a listen-only mode. 00:00:10.500 -- 00:00:13.763 Please be advised that today's conference is being recorded. 00:00:13.763 -- 00:00:17.226 After the speaker's presentation, there will be a question and answer session. 00:00:17.226 -- 00:00:22.371 To ask a question, please press star 1 1 on your telephone and wait for your name 00:00:22.371 -- 00:00:26.414 to be announced. To withdraw your question, please press star 1 1 again. 00:00:26.414 -- 00:00:30.052 I would now like to hand the conference over to your speaker today. 00:00:30.052 -- 00:00:35.516 Melissa Jarrell, Executive Director of Legal at Heron. 00:00:37.960 -- 00:00:40.623 Thank you, operator, and good morning, everyone. 00:00:40.623 -- 00:00:44.667 Thank you for joining us on the Heron Therapeutics conference call this morning to discuss 00:00:44.667 -- 00:00:49.630 the company's financial results for the quarter ended March 31st, 2025. 00:00:49.732 -- 00:00:55.178 With me today from Heron are Craig Collard, Chief Executive Officer, Ira Duarte, Executive 00:00:55.178 -- 00:01:00.115 Vice President, Chief Financial Officer, Bill Forbes, Executive Vice President, Chief 00:01:00.115 -- 00:01:04.902 Development Officer, and Kevin Werner, Senior Vice President, Medical Affairs Strategy 00:01:04.902 -- 00:01:09.508 and Engagement. For those of you participating via conference call, slides are made available 00:01:09.508 -- 00:01:14.335 via webcast and can also be accessed via the Investor Relations page of our website following 00:01:14.335 -- 00:01:17.059 the conclusion of today's call. 00:01:17.059 -- 00:01:20.8...